Analyst ratings
Across 28 analysts the consensus is a Strong Buy: 22 buy calls against 1 sell, with an average 12-month price target of $159.38.
NASDAQ: GILD · Drug Manufacturers - General
Over the past week, Gilead Sciences (GILD) drew about 46 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 27% bullish but is far apart: News runs 47% bullish while Reddit sits at just 0%. Wall Street is more constructive, with 22 of 28 analysts rating GILD a buy.
There is little buzz around GILD this week and little agreement on direction, which is why it reads as a Sell.
Wall Street’s 79% buy share sits next to a crowd that ranges from Reddit at 0% to News at 47%. No other tracker puts the two side by side.
Across 28 analysts the consensus is a Strong Buy: 22 buy calls against 1 sell, with an average 12-month price target of $159.38.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is cooling and the 3 sources disagree sharply, so the read is a Sell.
Analysts sit 52 points above the crowd average of 27%, the professionals are more constructive than retail. The split is inside the crowd: News reads 47% bullish while Reddit sits at 0%, a 47-point spread that single-source trackers miss.
Over the 30-day window, Gilead Sciences (GILD) buzz held subdued around 35.3 while the price drifted up 5.8% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 5.7M shares. Updated Oct 10, 2026. Over the last 7 trading days, GILD gained 2.5%. Buzz activity in the recent week averaged 37.2 and was variable, swinging between 27.0 and 49.8. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 17 of the 21 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for GILD and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live GILD sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Oct 10, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Strong Buy (22 / 5 / 1) |
| Crowd bullish (7d) | 27% |
| Avg price target | $159.38 |
| Most bullish source | News, 47% |
| Most bearish source | Reddit, 0% |
| Sentiment spread | 47 pts |
| Mentions (7d) | 46 |
| Market cap | $182.4B |
| P/E · Forward P/E | n/a · 15.6 |
| EPS · Beta | -$2.65 · 0.3 |
| Revenue (TTM) | $30.46B · -11% margin |
| Industry | Drug Manufacturers - General |
Based on aggregated sentiment from Reddit, X and News sources, Gilead Sciences (GILD) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 27% bullish across 3 active sources. Those sources contribute 46 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Gilead Sciences (GILD) is fairly quiet with 3 mentions over the last 7 days; the 30-day context spans 8 tracked subreddits. The 7-day tone is 0% bullish; 3-day activity momentum is falling, suggesting cooling attention.
The crowd reads bearish on Gilead Sciences (GILD), averaging 27% bullish across 3 tracked sources over the last 7 days. The two ends of the range are News at 47% bullish and Reddit at 0%, a 47-point spread. On the professional side, 22 of 28 analysts rate GILD a buy.
Of the 28 analysts covering Gilead Sciences (GILD), 22 rate it a buy, 5 a hold and 1 a sell, for a strong buy consensus. The average price target is $159.38. That puts the street ahead of the crowd, which averages 27% bullish.
Gilead Sciences (GILD)'s cross-source average is bearish at 27% bullish. All 3 tracked sources lean bearish. X reads 33% bullish, News reads 47% bullish and reddit coverage is the most negative at 0% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for Gilead Sciences (GILD) at 27% bullish. All 3 tracked sources lean bearish. The most bearish reading is reddit at 0% bullish. 3-day activity momentum is falling across Reddit and X and News. The sell signal carries 93/100 conviction.
X is the dominant discussion channel with 24 mentions (52% of total volume). News contributes 19 mentions and Reddit contributes 3 mentions. The cross-source average is bearish at 27% bullish. All 3 tracked sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. GILD's sell signal at 93/100 conviction reflects a bearish cross-source average at 27% bullish. All 3 tracked sources lean bearish. It is a research shortcut, not financial advice.
The GILD sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key